HC Wainwright's Rating of Sensei Biotherapeutics on 6/22/2026

On June 22, 2026, HC Wainwright updated its outlook on Sensei Biotherapeutics (NASDAQ:FTH) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
6/22/2026
Energy Fuels Inc stock logo
UUUU
Energy Fuels
Reiterated Rating
6/22/2026
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
Boost Price Target
6/22/2026
Achieve Life Sciences, Inc. stock logo
ACHV
Achieve Life Sciences
Reiterated Rating
6/22/2026
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
Reiterated Rating
6/22/2026
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
Reiterated Rating
6/22/2026
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
Reiterated Rating
More Ratings From HC Wainwright